Alembic Pharma gets final US nod for generic Mesalamine capsules

Alembic Pharma gets final US nod for generic Mesalamine capsules The approval granted by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules of strength 0.375 g, the company said in a statement.

from Moneycontrol Business News https://ift.tt/Jh1goic
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...